Investment spruiker James Mawhinney has successfully appealed a 20-year fundraising ban, but temporary injunction prevents him from marketing financial products.
Pelvic Mesh Implant Appeal Begins in Sydney
A Sydney court will begin hearing a multinational pharmaceutical giant’s challenge to a landmark ruling that pelvic mesh implants caused debilitating injuries to hundreds of Australian women.
The November 2019 ruling found three companies in the Johnson & Johnson group had acted negligently and concealed the true extent of complications from the pelvic implants.
More than 1350 Australian women had joined the class action, launched in 2012.
But Johnson & Johnson on Feb. 1 is expected to tell the Full Court of the Federal Court the trial judge made more than a dozen errors.
Those errors include giving inadequate weight to pelvic surgeons’ evidence and reversing the onus of proof, according to court documents.